- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04652856
Neurocognitive Basis of Attention and Eye Movement Guidance in the Real World Scenes
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The ability to conduct a visual search for an object in a naturalistic scene is a crucial component of everyday interactions with the environment. This process requires the recognition of different items, accessing stored semantic knowledge about those items and their relationships with other objects, and guiding vision based on that knowledge. Classical models of attention emphasize low-level visual salience maps for attentional guidance. However, behavioral studies increasingly support a role for object knowledge in guiding attention and eye movements. Despite strong behavioral evidence that conceptual information about objects and scenes is critical for real world guidance of attention, very little is known about the neural basis of the guidance of attention based on meaning.
Previous human imaging studies have identified several brain regions that represent object and scene/context knowledge as it relates to visual recognition. In particular, regions of the temporal lobes (inferior temporal regions (ITC), parahippocampal cortex (PHC), and the hippocampus) are critical for perceiving and understanding objects, but little is known about the role of these individual regions in how they interact to guide attention and eye movements in real-world scenes.
Electrical brain stimulation is routinely performed clinically in the surgical treatment of epilepsy patients, both intraoperatively and using implanted electrodes. It is used as standard of care both to map eloquent brain function prior to surgical treatment for epilepsy and to map the seizure network. The purpose of this study is to gain a better understanding of the information flow and neural dynamics of the brain, examining the impact of electrical brain stimulation on stimulus search time, accuracy, and eye movement trajectories.
Studietype
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Forente stater, 15213
- UPMC Presbyterian
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Have intracranial EEG electrodes implanted for stage II epilepsy planning.
- Have adequate cognitive and communication ability to give informed consent, understand instructions, and follow direction.
- Be able to understand the tasks and provide responses.
- IQ > 75 (done as part of standard-of-care neuropsychological testing as part of the surgical treatment for epilepsy)
- Speak English
Exclusion Criteria:
- Inability to understand or perform the tasks outlined in this protocol
- In excessive postoperative discomfort.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Grunnvitenskap
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Electrical and Sham Electrical Brain Stimulation
Electrical brain stimulation and sham electrical brain stimulation will be administered to all participants.
|
Electrical Brain Stimulation (EBS) will be used to disrupt local neural activity in inferior temporal regions (ITC), parahippocampal cortex (PHC), the hippocampus, and control regions.
The effects of EBS will be examined on attention and eye movement behavior, and all participants will receive both EBS and sham electrical brain stimulation.
Sham electrical brain stimulation (SEBS) will be applied to inferior temporal regions (ITC), parahippocampal cortex (PHC), the hippocampus, and control regions.
The effects of SEBS will be examined on attention and eye movement behavior, and all participants will receive both SEBS and EBS.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Incidence of eye fixations during electrical brain stimulation (EBS) vs. sham electrical brain stimulation (SEBS).
Tidsramme: Eye fixation incidence will be assessed during the intervention, through study completion, up to 1 week on average.
|
Eye fixations will be assessed using an eye tracking device, which collects videos of eye movements.
Participants will be presented with an image of a scene, and asked to locate a target object.
The incidence of eye fixations occurring before participants locate the target object will be measured at preferred and control brain regions during EBS and SEBS.
|
Eye fixation incidence will be assessed during the intervention, through study completion, up to 1 week on average.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Search time for target object during EBS vs. SEBS.
Tidsramme: Search Time will be assessed during the intervention, through study completion, up to 1 week on average.
|
Visual search time will be assessed by asking participants to answer a simple question about a target object in an image of a scene as quickly and accurately as possible.
The question will presented to the participants, followed by the image of the scene.
The search time to locate the target object and respond to the question will be measured at preferred and control brain regions during EBS and SEBS.
|
Search Time will be assessed during the intervention, through study completion, up to 1 week on average.
|
Identification accuracy during EBS vs. SEBS.
Tidsramme: Identification accuracy will be assessed during the intervention, through study completion, up to 1 week on average.
|
Identification accuracy rate will be assessed based on the participants' correct responses for identifying a target object in an image of a scene (described in Outcomes 1 and 2).
The search time to locate the target object will be measured at preferred and control brain regions during EBS and SEBS.
|
Identification accuracy will be assessed during the intervention, through study completion, up to 1 week on average.
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Avniel S Ghuman, PhD, University of Pittsburgh
Studierekorddatoer
Studer hoveddatoer
Studiestart (Forventet)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- STUDY19090010
- 1R21EY030297-01A1 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Electrical Brain Stimulation
-
Abbott Medical DevicesAvsluttetDepressiv lidelse, major | Unipolar depresjonForente stater, Canada, Storbritannia
-
University of British ColumbiaFullførtDyp hjernestimulering | Spasmodisk dysfoni | Laryngeal dystoniCanada
-
Stanford UniversityFullførtParkinsons sykdomForente stater
-
George Washington UniversityFullførtMesial temporallappepilepsiForente stater
-
University Hospital, GrenobleFullførtOvervekt | KlyngehodepineFrankrike
-
Beijing Pins Medical Co., LtdPeking Union Medical College HospitalFullført
-
University of MinnesotaRekrutteringParkinsons sykdomForente stater
-
North Bristol NHS TrustUniversity of BristolUkjent
-
Tianjin Huanhu HospitalRekrutteringParkinsons sykdom | Kognitiv sviktKina
-
Boston Scientific CorporationRekrutteringEssensiell skjelvingTyskland, Korea, Republikken, Canada, Belgia, Ungarn, Spania, Portugal, Italia